[Toward the overcoming of controversies about adjuvant chemotherapy in patients radically resected for NSCLC stage IA].
The Author remarks the dispute about the adjuvant chemotherapy in patients with completely resected NSCLC stage IA. The tendency to overcoming all these disputes on the basis of relevant data published in the pneumological literature, is taking shape. The most active role in this field of research is played by the pathologists as well as by thoracic surgeons in the interdisciplinary perspective concerning the new changed “scenario” after the 7th Edition 2009 of TNM Staging System.